4.8 Review

Neuro-Immune Cross-Talk in the Striatum: From Basal Ganglia Physiology to Circuit Dysfunction

Journal

FRONTIERS IN IMMUNOLOGY
Volume 12, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2021.644294

Keywords

basal ganglia; nucleus striatum; immune system; synaptic transmission; synaptic plasticity

Categories

Funding

  1. Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorder, Fresco Parkinson Institute, New York University School of Medicine

Ask authors/readers for more resources

The basal ganglia network, traditionally known for its role in motor learning and movement execution, is now recognized as a key regulator of cognitive and emotional processes. The striatum acts as an input station in the circuit, influencing the functional output of the whole system through synaptic plasticity. The immune system's regulation of synaptic activity in the striatum may play a role in inflammatory and degenerative CNS diseases.
The basal ganglia network is represented by an interconnected group of subcortical nuclei traditionally thought to play a crucial role in motor learning and movement execution. During the last decades, knowledge about basal ganglia physiology significantly evolved and this network is now considered as a key regulator of important cognitive and emotional processes. Accordingly, the disruption of basal ganglia network dynamics represents a crucial pathogenic factor in many neurological and psychiatric disorders. The striatum is the input station of the circuit. Thanks to the synaptic properties of striatal medium spiny neurons (MSNs) and their ability to express synaptic plasticity, the striatum exerts a fundamental integrative and filtering role in the basal ganglia network, influencing the functional output of the whole circuit. Although it is currently established that the immune system is able to regulate neuronal transmission and plasticity in specific cortical areas, the role played by immune molecules and immune/glial cells in the modulation of intra-striatal connections and basal ganglia activity still needs to be clarified. In this manuscript, we review the available evidence of immune-based regulation of synaptic activity in the striatum, also discussing how an abnormal immune activation in this region could be involved in the pathogenesis of inflammatory and degenerative central nervous system (CNS) diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Clinical features and outcome of patients with autoimmune cerebellar ataxia evaluated with the Scale for the Assessment and Rating of Ataxia

Valentina Damato, Claudia Papi, Gregorio Spagni, Amelia Evoli, Gabriella Silvestri, Gianvito Masi, Eleonora Sabatelli, Lucia Campetella, Andrew McKeon, Francesca Andreetta, Vittorio Riso, Gabriele Monte, Marco Luigetti, Guido Primiano, Paolo Calabresi, Raffaele Iorio

Summary: The study evaluated the long-term outcomes of patients with autoimmune cerebellar ataxia, distinguishing between paraneoplastic and non paraneoplastic cases. Neural autoantibodies were detected in a significant portion of patients, with all patients receiving immunotherapy. Patients with paraneoplastic cerebellar syndrome had higher SARA scores compared to idiopathic ACA patients, and those with good outcomes had lower SARA scores.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Article Pharmacology & Pharmacy

Remission of functional motor symptoms following esketamine administration in a patient with treatment-resistant depression: a single-case report

Lorenzo Moccia, Pierluigi Lanzotti, Maria Pepe, Laura Palumbo, Delfina Janiri, Giovanni Camardese, Anna Rita Bentivoglio, Marco Di Nicola, Paolo Calabresi, Gabriele Sani

Summary: Functional movement disorders (FMD) are abnormal involuntary movements not consistent with neurological diseases. They often co-occur with mood and anxiety disorders and have poor clinical outcomes. This case report presents the successful treatment of FMD symptoms in a patient with treatment-resistant depression (TRD) using esketamine.

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2022)

Article Clinical Neurology

Mechanical thrombectomy in acute ischemic stroke due to large vessel occlusion in the anterior circulation and low baseline National Institute of Health Stroke Scale score: a multicenter retrospective matched analysis

Andrea Maria Alexandre, Iacopo Valente, Alessandro Pedicelli, Angelo Maria Pezzullo, Francesca Colo, Luca Scarcia, Andrea Romi, Mariangela Piano, Antonio Macera, Joseph Domenico Gabrieli, Giacomo Cester, Antonio Armando Caragliano, Sergio Lucio Vinci, Maria Ruggiero, Christian Commodaro, Andrea Saletti, Guido Andrea Lazzarotti, Mirco Cosottini, Valerio Da Ros, Luigi Bellini, Emilio Lozupone, Adriana Paladini, Valerio Brunetti, Roberta Morosetti, Giovanni Frisullo, Paolo Calabresi, Giacomo Della Marca, Aldobrando Broccolini

Summary: This study evaluated the effectiveness of mechanical thrombectomy in patients with acute ischemic stroke due to large vessel occlusion and baseline mild neurological symptoms. After propensity score matching, patients who received immediate mechanical thrombectomy had a higher chance of excellent outcome at 90 days compared to those who received best medical management/rescue mechanical thrombectomy, with a similar risk of death.

NEUROLOGICAL SCIENCES (2022)

Review Clinical Neurology

An Updated Overview of the Magnetic Resonance Imaging of Brain Iron in Movement Disorders

Nicola Tambasco, Pasquale Nigro, Andrea Chiappiniello, Federico Paolini Paoletti, Sara Scialpi, Simone Simoni, Pietro Chiarini, Lucilla Parnetti

Summary: Brain iron load is a significant factor in movement disorders, and its accumulation is related to basal ganglia degeneration. The current literature on the use of Magnetic Resonance Imaging for Brain Iron Detection and Quantification (MRI-BIDQ) in neurodegenerative processes underlying movement disorders is reviewed.

BEHAVIOURAL NEUROLOGY (2022)

Editorial Material Clinical Neurology

NfL as Analogue of C-Reactive Protein in Neurologic Diseases

Lorenzo Gaetani, Lucilla Parnetti

NEUROLOGY (2022)

Review Clinical Neurology

Psychiatric symptoms in multiple sclerosis: a biological perspective on synaptic and network dysfunction

Giulia Menculini, Andrea Mancini, Lorenzo Gaetani, Laura Bellingacci, Alfonso Tortorella, Lucilla Parnetti, Massimiliano Di Filippo

Summary: Psychiatric symptoms in multiple sclerosis (MS) are diverse, ranging from clear-cut psychiatric disorders to isolated psychopathological manifestations. These clinical features often go misdiagnosed, receive suboptimal treatment, and are not adequately assessed in disease activity quantification. Pathogenesis of psychiatric symptoms in MS involves emotional reactions to the disability caused by the disease as well as structural damage in the central nervous system. Biological perspective reveals that MS-related psychiatric manifestations are associated with synaptic and neural network dysfunction due to diffuse brain damage from inflammation and neurodegeneration.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2023)

Editorial Material Clinical Neurology

On the Track of a-Synuclein in the Body Skin Biopsies for Diagnosing Synucleinopathies?

Lucilla Parnetti, Giovanni Bellomo

Summary: Multiple system atrophy (MSA) is an aggressive form of synucleinopathy, characterized by misfolded a-syn accumulations mainly in glial cells. Making a clinical diagnosis of MSA is challenging, even for experienced clinicians. Therefore, there is a need for reliable biomarkers to detect the presence and distinguish different synucleinopathies, as disease-modifying treatments are available for some.

NEUROLOGY (2023)

Review Clinical Neurology

Advances in understanding the function of alpha-synuclein: implications for Parkinson's disease

Paolo Calabresi, Giulia Di Lazzaro, Gioia Marino, Federica Campanelli, Veronica Ghiglieri

Summary: The critical role of alpha-synuclein in Parkinson's disease has been discovered, but current treatments still face challenges. Developing cellular and animal models helps understand the physiological and pathological functions of alpha-synuclein, as well as the pathogenesis of Parkinson's disease.

BRAIN (2023)

Article Clinical Neurology

Redefinition of dementia care in Italy in the era of amyloid-lowering agents for the treatment of Alzheimer's disease: an expert opinion and practical guideline

Massimo Filippi, Giordano Cecchetti, Annachiara Cagnin, Camillo Marra, Flavio Nobili, Lucilla Parnetti, Federica Agosta

Summary: Currently, no disease-modifying therapies are available for Alzheimer's disease (AD) in Europe. However, evidence from clinical trials suggests that anti-beta amyloid (Aβ) monoclonal antibodies (mAbs) may be authorized for marketing in the near future. A group of prominent AD clinical experts in Italy met to discuss patient selection and management strategies, recognizing the need for significant changes in dementia care to implement disease-modifying therapies. They emphasized the importance of a biological diagnosis using amyloid- and tau-related biomarkers, as well as specialized diagnostic work-up and exclusion criteria assessment by neurology specialists. The experts also proposed a reorganization of dementia and cognitive decline centers into three levels with defined tasks and requirements.

JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease

Lorenzo Barba, Samir Abu-Rumeileh, Steffen Halbgebauer, Giovanni Bellomo, Federico Paolini Paoletti, Lorenzo Gaetani, Patrick Oeckl, Petra Steinacker, Federico Massa, Lucilla Parnetti, Markus Otto

Summary: This study aimed to investigate the correlation between CSF biomarkers and the presence of AD copathology in LBD patients and determine their usefulness in differentiating LBD patients with different AT(N) profiles. The results showed that CSF levels of synaptic and neuroaxonal damage biomarkers were significantly increased in AD patients compared to LBD patients and controls. Among LBD patients, those with A+T+ profiles had higher levels of biomarkers for synaptic and neuroaxonal degeneration compared to those with A-T- profiles.

NEUROLOGY (2023)

Review Cell Biology

Alpha-synuclein in Parkinson's disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction

Paolo Calabresi, Alessandro Mechelli, Giuseppina Natale, Laura Volpicelli-Daley, Giulia Di Lazzaro, Veronica Ghiglieri

Summary: Although the discovery of the role of alpha-synuclein in Parkinson's disease is 25 years old, it still represents a significant milestone in PD research. Abnormal forms of alpha-syn trigger neuronal death and synaptic dysfunction in PD and other synucleinopathies through various mechanisms. Understanding these early mechanisms is crucial for identifying biomarkers and developing disease-modifying therapies targeting alpha-syn.

CELL DEATH & DISEASE (2023)

Editorial Material Clinical Neurology

Advances in Diagnosis and Prognosis of Parkinson Disease

Lucilla Parnetti, Giovanni Bellomo

Summary: The biological definition of Parkinson's disease is still uncertain. Recent advances in fluid biomarkers have been made, but there are limitations in accurately capturing the multiple biological features of the disease.

NEUROLOGY (2023)

Editorial Material Clinical Neurology

Lipoproteins and α-synuclein in cerebrospinal fluid in Parkinson's disease: Dangerous liaisons on the road to neurodegeneration?

Lucilla Parnetti, Giovanni Bellomo, Yaroslau Compta

PARKINSONISM & RELATED DISORDERS (2023)

Article Clinical Neurology

Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum

Silvia Paciotti, Anna Lidia Wojdala, Giovanni Bellomo, Andrea Toja, Elena Chipi, Sander R. R. Piersma, Thang V. V. Pham, Lorenzo Gaetani, Connie R. R. Jimenez, Lucilla Parnetti, Davide Chiasserini

Summary: This study aimed to validate the potential value of four metabolism-related proteins (PKM, ALDO, UCHL1 and FABP3) as new cerebrospinal fluid (CSF) biomarkers for Alzheimer's disease (AD) and their involvement in AD pathogenesis. The results showed that CSF levels of UCHL1 and FABP3, as well as PKM activity, were significantly increased in AD patients, even at the preclinical stage. UCHL1 and FABP3 showed good performance in discriminating early AD patients from controls, while PKM provided the best performance in distinguishing between frontotemporal dementia (FTD) and mild cognitive impairment (MCI).

ALZHEIMERS RESEARCH & THERAPY (2023)

Article Psychology, Clinical

Repeatable Battery for the Assessment of Neuropsychological Status: Italian Normative Data for Older Adults

Elena Chipi, Daniela Fruttini, Nicola Salvadori, Chiara Montanucci, Elisa Siena, Giulia Menculini, Claudia Mazzeschi, Lucilla Parnetti

Summary: This study assessed the impact of age, education, and gender on RBANS subtests, indexes, and total scores in a larger sample of older adults. The obtained normative data showed good concordance with the original norms and suggested that RBANS is not significantly affected by education. The development of a free-to-use Excel spreadsheet to calculate percentiles for individual scores could make RBANS a more precise measure for detecting subtle cognitive deficits in prevention studies.

ARCHIVES OF CLINICAL NEUROPSYCHOLOGY (2023)

No Data Available